How does OMIC's PS Ratio compare to its peers?

OMIC is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (7.1x).

How does OMIC's PS Ratio compare vs other companies in the CA Pharmaceuticals Industry?

OMIC is good value based on its Price-To-Sales Ratio (0.9x) compared to the Canadian Pharmaceuticals industry average (1x).

What is OMIC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate OMIC's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of OMIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

OMIC (CA$0.05) is trading below our estimate of [[fair value]] (CA$0.75)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

OMIC Stock Overview

Optima Medical Innovations Corp. delivers pathways to innovative, science-based health, and wellness solutions. More details

OMIC fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Trading at 94% below our estimate of its fair value

Earnings have grown 1.5% per year over the past 5 years

Risk Analysis

Does not have a meaningful market cap (CA$2M)

Shares are highly illiquid

Does not have meaningful revenue ($2M)

Latest financial reports are more than 6 months old

My Notes

Capture your thoughts, links and company narrative

Optima Medical Innovations Corp. Competitors

1933 Industries

CNSX:TGIF

CA$2.5m

Captor Capital

CNSX:CPTR

CA$2.4m

Craftport Cannabis

CNSX:CFT

CA$2.7m

Hempshire Group

TSXV:HMPG

CA$2.1m

Price History & Performance

Summary of share price highs, lows and changes for Optima Medical Innovations
Historical stock prices
Current Share Price	CA$0.045
52 Week High	CA$0.24
52 Week Low	CA$0.03
Beta	2.88
1 Month Change	0%
3 Month Change	0%
1 Year Change	-40.00%
3 Year Change	-87.14%
5 Year Change	n/a
Change since IPO	-99.40%

Recent updates

Shareholder Returns

	OMIC	CA Pharmaceuticals	CA Market
7D	0%	2.1%	1.7%
1Y	-40.0%	-30.3%	16.1%

Return vs Industry: OMIC underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.

Return vs Market: OMIC underperformed the Canadian Market which returned -0.7% over the past year.

Price Volatility

Is OMIC's price volatile compared to industry and market?
OMIC volatility
OMIC Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	12.1%
Market Average Movement	8.1%
10% most volatile stocks in CA Market	17.4%
10% least volatile stocks in CA Market	3.0%

Stable Share Price: OMIC has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine OMIC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Ommid Faghani	www.tokicorp.com

Optima Medical Innovations Corp. produces and sells hemp-based cannabidiol (CBD) products in Canada and internationally. It offers industrial hemp-derived CBD oil, airless metered pens, capsules, topicals, and tinctures. The company also operates multidisciplinary pain clinics, which focuses on the treatment of chronic pain, including comprehensive, medical, and interventional pain management; independent medical evaluations; physiotherapy and chiropractic care; and medical cannabis and platelet rich plasma therapy, as well as mindfulness teaching.

Optima Medical Innovations Corp. Fundamentals Summary

How do Optima Medical Innovations's earnings and revenue compare to its market cap?
OMIC fundamental statistics
Market cap	CA$2.14m
Earnings (TTM)	-CA$472.95k
Revenue (TTM)	CA$2.51m

0.9x

P/S Ratio

-4.5x

P/E Ratio

Is OMIC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OMIC income statement (TTM)
Revenue	US$1.94m
Cost of Revenue	US$1.55m
Gross Profit	US$392.10k
Other Expenses	US$757.44k
Earnings	-US$365.34k

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0077
Gross Margin	20.19%
Net Profit Margin	-18.81%
Debt/Equity Ratio	12.6%

How did OMIC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/08/06 12:55
End of Day Share Price	2022/05/09 00:00
Earnings	2021/09/30
Annual Earnings	2020/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Optima Medical Innovations Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution